Risk of early death after treatment with curative intent for head and neck squamous cell carcinoma: a retrospective population-based study
Early death risk is increased in older patients and those with advanced-stage HNSCC. Elevated thrombocyte count requires further studies to assess its utility as a potential clinical marker.
Authors
- Sami Ventelä (ORCID: https://orcid.org/0000-0001-6672-6662)
- Rayan Nikkilä (ORCID: https://orcid.org/0000-0002-0999-2734)
- Leif Bäck (ORCID: https://orcid.org/0000-0001-8383-7671)
- Aaro Haapaniemi (ORCID: https://orcid.org/0000-0003-3097-1118)
- Mirna Bazina (ORCID: https://orcid.org/0009-0002-0520-2958)
- Antti Mäkitie
Institutions
- Åbo Akademi University (FI)
- Karolinska University Hospital (SE)
- University of Helsinki (FI)
- University of Turku (FI)
- Turku Centre for Computer Science (FI)
- Helsinki University Hospital (FI)
- Turku University Hospital (FI)
- Karolinska Institutet (SE)
- Finnish Cancer Registry (FI)
- Päijät-Hämeen Keskussairaala (FI)
- Hospital District of Helsinki and Uusimaa (FI)
Publication Details
- Journal
- Acta Oncologica
- Published
- 2025-03-04
- DOI
- https://doi.org/10.2340/1651-226x.2025.42202
- Citations
- 1
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.85